US FDA expands approval for Travere Therapeutics' drug for rare kidney disease

Travere Therapeutics

13/04/2026 23:19

April 13 (Reuters) - The U.S. Food and Drug Administration has approved the expanded use of Travere Therapeutics' TVTX.O drug to treat a rare kidney disorder, the company said on Monday.

 (Reporting by Unnamalai L and Siddhi Mahatole in Bengaluru; Editing by Tasim Zahid)

 ((Unnamalai.L@thomsonreuters.com;))